Stratpharma’s dermatology team has many years of international experience in the dermatological therapeutic franchise with a current focus on scars. These products for scar management and abnormal scar prevention can be used alone or in combination with other more invasive therapies. The current products including Strataderm® hold existing registrations and are available in over 38 countries in Europe, Africa, North America and Asia.
Stratpharma, in conjunction with its development partners, is extending its focus by developing a range of innovative products for topical dermatology. These new products will extend upon the immediate focus on scar and late stage wound healing.
Using patented polymer technology, these products will deliver significant benefits to patients through ease of use, greater activation of API’s, safety and stability profiles as well as advances in gas permeability occlusion and protection.
Pipeline products will include those with problematic trans-dermal API delivery in indications that will benefit from the inherent physical properties of the “drug delivery system”.
Interested development partners should contact Stratpharma.
For more information please visit our product websites:
Strataderm®, Silicone Gel for professional scar therapy, www.strataderm.com
Stratamed®, Scar therapy gel for the use on non epithelialized wounds and compromised skin, www.stratamed.com